Amgen (NASDAQ: AMGN) net income
Amgen reported a net profit of $7,711m for fiscal 2025, 88.5% more than in fiscal 2024 ($4,090m). Its net margin was 21.0%. Earnings per share were $14.33.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $7,711m | +88.5% | 21.0% | $14.33 |
| 2024 | $4,090m | −39.1% | 12.2% | $7.62 |
| 2023 | $6,717m | +2.5% | 23.8% | $12.56 |
| 2022 | $6,552m | +11.2% | 24.9% | $12.18 |
| 2021 | $5,893m | −18.9% | 22.7% | $10.34 |
| 2020 | $7,264m | −7.4% | 28.6% | $12.40 |
| 2019 | $7,842m | −6.6% | 33.6% | $12.96 |
| 2018 | $8,394m | +324.2% | 35.3% | $12.70 |
| 2017 | $1,979m | −74.4% | 8.7% | $2.71 |
| 2016 | $7,722m | — | 33.6% | $10.32 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of Amgen
- How much did Amgen earn in fiscal 2025?
- Amgen reported a net profit of $7,711m for fiscal 2025. In fiscal 2024 it reported a net profit of $4,090m.
- What are the earnings per share of Amgen?
- They were $14.33 in fiscal 2025, compared with $7.62 in fiscal 2024.
- What is the net margin of Amgen?
- In fiscal 2025 its net profit was 21.0% of its revenue.
- What was the most profitable year for Amgen?
- Of its last 10 fiscal years, fiscal 2018, with $8,394m.
- Where do the figures for Amgen come from?
- From the annual report (Form 10-K) that Amgen files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Amgen files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Amgen: the Amgen page · annual accounts · revenue · dividends paid · insider transactions.
Dividend per share of Amgen by fiscal year, with the filing behind every figure: Amgen dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.